undamentalytics Newsletter
Sign in

Bioventus Inc. revenue

Bioventus Inc.'s revenue was $568m in fiscal 2025, down 0.9% on the year before. Since fiscal 2019 ($340m) it has grown at a compound 8.9% a year. Over the last twelve months it was $586m.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMSept 2026
Revenue340321431512512573568586
Growth on the year before—−5.6%+34.2%+18.8%+0.0%+11.9%−0.9%—
Gross profit249234303331328388388402
Gross margin73.3%72.7%70.3%64.6%64.1%67.7%68.3%68.7%

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Where the revenue comes from

Fiscal year to December 31, 2025
Segments
Line of business Revenue Share YoY
United States $502M 88.4% ▼ 0.9%
International $66M 11.6% ▼ 0.7%
Geography
Region Revenue Share YoY
United States $502M 88.4% ▼ 0.9%
Outside the US $66M 11.6% ▼ 0.7%

From Bioventus Inc.'s 10-K filed March 5, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Revenue against peers

Health Care Equipment: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Bioventus Inc. $586m 3.9% 5.2%
Atricure, Inc. $570m 13.9% 15.9%
Transmedics Group, Inc. $668m 25.8% 64.2%
Glaukos Corp $690m 46.9% 31.5%
Novocure Ltd $725m 12.9% 12.9%
Artivion, Inc. $471m 16.4% 12.8%

Compare with peers

Head to head: ATRC vs BVSBVS vs TMDXBVS vs GKOSAORT vs BVS

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Bioventus Inc.'s SEC filings (10-K and 10-Q), retrieved November 3, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Bioventus Inc.